Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.33 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.33 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6150843 | 0.95 | SMPD1 (0.40) | CA2CA1SMPD1ACE2GPR84 | |
| SCHEMBL6152186 | 0.87 | CA2 (0.36) | CA2MAPK1CA1SMPD1ALDH1A1 | |
| SCHEMBL9951290 | 0.82 | ALDH1A1 (0.42) | CA2MAPK1CA1SMPD1ALDH1A1 | |
| SCHEMBL6150839 | 0.82 | SMPD1 (0.41) | CA2CA1SMPD1ALDH1A1ACE2 | |
| SCHEMBL3651798 | 0.79 | SMPD1 (0.42) | CA2CA1SMPD1ALDH1A1ACE2 | |
| SCHEMBL27584516 | 0.77 | SMPD1 (0.48) | CA1SMPD1ACE2GPR84FFAR1 | |
| SCHEMBL1042135 | 0.76 | CA2 (0.42) | CA2MAPK1CA1ALDH1A1ACE2 | |
| SCHEMBL28326424 | 0.75 | GPR84 (0.52) | SMPD1ACE2GPR84FFAR1 | |
| SCHEMBL3292096 | 0.72 | ALDH1A1 (0.41) | CA2MAPK1CA1ALDH1A1 | |
| SCHEMBL15661863 | 0.71 | ACE2 (0.44) | CA2MAPK1CA1ACE2SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1527045-A1 | NITRIC OXIDE RELEASING PRODRUGS OF DIARYL-2-(5H)-FURANONES AS CYCLOOXYGENASE-2 INHIBITORS | Merck Frosst Canada & Co. (CA) | 2005-05-04 | — | — | EP | disclosed |
| WO-2004011421-A1 | NITRIC OXIDE RELEASING PRODRUGS OF DIARYL-2-(5H)-FURANONES AS CYCLOOXYGENASE-2 INHIBITORS | MERCK FROSST CANADA & CO. (CA) | 2004-02-05 | — | — | WO | disclosed |